Boston Scientific Corporation’s BSX elective procedure deferrals amid the pandemic are weighing on the stock. Further, unfavorable currency movement has been a major dampener. The stock currently ...
source http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=A16EFAA7A82F461188AC73A0257F7ADF&url=https%3a%2f%2fwww.nasdaq.com%2farticles%2fboston-scientific-bsx-hit-by-procedure-deferrals-amid-covid&c=6321704421775881106&mkt=en-us
No comments:
Post a Comment